May 6, 2025 07:45AM Silence Therapeutics (SLN) Welcomes Tim McInerney to Board of Directors

Mar 7, 2025 06:46AM H.C. Wainwright Reiterates Buy Rating on Silence Therapeutics (SLN)

Mar 4, 2025 04:55PM Silence Therapeutics (SLN) PT Lowered to $45 at Morgan Stanley

Feb 27, 2025 03:36PM Silence Therapeutics (SLN) PT Lowered to $30 at Jefferies

Feb 11, 2025 03:58AM Goldman Sachs Starts Silence Therapeutics (SLN) at Sell

Feb 3, 2025 06:49AM H.C. Wainwright Reiterates Buy Rating on Silence Therapeutics (SLN)

Dec 9, 2024 07:32AM Silence Therapeutics (SLN) Presents Promising Phase 1 Data in Polycythemia Vera Patients at the American Society of Hematology (ASH) Annual Meeting

Dec 2, 2024 06:04AM BMO Capital Reiterates Silence Therapeutics (SLN) at Outperform, 'expect a positive Pelacarsen readout to drive 100-200%+ upside"

Nov 20, 2024 07:24AM H.C. Wainwright Reiterates Buy Rating on Silence Therapeutics (SLN)

Nov 19, 2024 02:55PM BMO Capital Reiterates Outperform Rating on Silence Therapeutics (SLN)

Nov 18, 2024 02:32PM Silence Therapeutics (SLN) Presents Late-Breaking Phase 2 Zerlasiran Data at 2024 American Heart Association Annual Meeting

Sep 2, 2024 10:23AM Jefferies Starts Silence Therapeutics (SLN) at Buy

Aug 30, 2024 06:53AM H.C. Wainwright Reiterates Buy Rating on Silence Therapeutics (SLN)

Aug 16, 2024 07:51AM BMO Capital Reiterates Outperform Rating on Silence Therapeutics (SLN)

Jun 28, 2024 06:40AM H.C. Wainwright Reiterates Buy Rating on Silence Therapeutics (SLN)

Jun 27, 2024 07:30AM Silence Therapeutics (SLN) Announces Positive Results from Ongoing SANRECO Phase 1 Study of Divesiran in Polycythemia Vera Patients

Jun 24, 2024 08:33AM Silence Therapeutics (SLN) to Receive $2M Cash Milestone from Hansoh Pharma

Jun 21, 2024 06:34AM H.C. Wainwright Reiterates Buy Rating on Silence Therapeutics (SLN)

Jun 20, 2024 07:32AM Silence Therapeutics (SLN) Announces Positive Topline 48-Week Data from Phase 2 Study of Zerlasiran

Jun 17, 2024 08:56AM BMO Capital Reiterates Outperform Rating on Silence Therapeutics (SLN)